PRediction of acute coronary syndrome in acute ischemic StrokE (PRAISE) – protocol of a prospective, multicenter trial with central reading and predefined endpoints
Christian H. Nolte(Charité - Universitätsmedizin Berlin), Matthias Endres(German Center for Neurodegenerative Diseases), Burkert Pieske(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Gabor C. Petzold(University Hospital Bonn), Jan F. Scheitz(Humboldt-Universität zu Berlin), Hugo A. Katus(Heidelberg University), Karl Wegscheider(Universität Hamburg), Vera Regitz‐Zagrosek(Charité - Universitätsmedizin Berlin), Martin Dichgans(Munich Cluster for Systems Neurology), Andreas M. Zeiher(Goethe University Frankfurt), Simon Litmeier(Charité - Universitätsmedizin Berlin), Regina von Rennenberg(Humboldt-Universität zu Berlin), Ulf Landmesser(Deutsches Herzzentrum der Charité), Stephan Blankenberg(German Centre for Cardiovascular Research), David M. Leistner(University of Salzburg)
Cited by 19
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k